| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/14/2012 | US8114911 Prostaglandin compounds for the treatment of obesity |
| 02/14/2012 | US8114910 Acidic composition |
| 02/14/2012 | US8114909 Treating or preventing restless legs syndrome using prodrugs of GABA analogs |
| 02/14/2012 | US8114907 Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells |
| 02/14/2012 | US8114906 Essential fatty acids in the treatment and/or inhibition of depression in patients with coronary heart or artery disease |
| 02/14/2012 | US8114903 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids |
| 02/14/2012 | US8114902 2-aminobutanol compound and use thereof for medical purposes |
| 02/14/2012 | US8114901 Crystalline 2,5-dione-3-(1-methyl-1H-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1H-indol-3-yl]-1H-pyrrole mono-hydrochloride |
| 02/14/2012 | US8114900 Amorphous carvedilol dihydrogen phosphate |
| 02/14/2012 | US8114899 2H- or 3H-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof |
| 02/14/2012 | US8114898 Compositions and methods for treating purpura |
| 02/14/2012 | US8114896 Method and composition for potentiating an opiate analgesic |
| 02/14/2012 | US8114895 Use of bipyridine compound ‘Caerulomycin A’ derivatives and analogs thereof as immunosuppressive agents |
| 02/14/2012 | US8114894 Bicyclic compounds and methods of making and using same |
| 02/14/2012 | US8114893 Compounds and methods of use |
| 02/14/2012 | US8114892 Methods and compositions for the treatment of Parkinson's Disease |
| 02/14/2012 | US8114891 4-substituted quinuclidine derivatives, methods of production, pharmaceutical uses thereof |
| 02/14/2012 | US8114890 Anti-constipation composition |
| 02/14/2012 | US8114889 Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes |
| 02/14/2012 | US8114888 Isothiazoloquinolones and related compounds as anti-infective agents |
| 02/14/2012 | US8114887 Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 02/14/2012 | US8114886 Pyridylmethylsulfone derivative |
| 02/14/2012 | US8114885 Chemical compounds |
| 02/14/2012 | US8114884 CXCR4 antagonists for the treatment of medical disorders |
| 02/14/2012 | US8114883 Polymer formulations for delivery of bioactive materials |
| 02/14/2012 | US8114882 Antitumor agents; kinase inhibitors; angiogenesis inhibitors; arteriosclerosis ; antiinflammatory agents |
| 02/14/2012 | US8114881 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial |
| 02/14/2012 | US8114880 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid MTP inhibiting compounds |
| 02/14/2012 | US8114879 Piperazine derivatives useful as CCR5 antagonists |
| 02/14/2012 | US8114878 PDE4 (Phosphodiesterase) inhibitors; respiratory diseases, gastrointestinal diseases, inflammation the joints, skin or eyes, cancers, or diseases of the peripheral or central nervous system |
| 02/14/2012 | US8114877 Organic compounds |
| 02/14/2012 | US8114876 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 02/14/2012 | US8114875 Substituted N-heterocyclic compounds and their use as dopamine D3 receptor ligands |
| 02/14/2012 | US8114874 Substituted acetylenic imidazo[1,2-B]pyridazine compounds as kinase inhibitors |
| 02/14/2012 | US8114873 1,4-disubstituted naphthalenes as inhibitors of p38 map kinase |
| 02/14/2012 | US8114872 Triazolyl aminopyrimidine compounds |
| 02/14/2012 | US8114871 3-amido-pyrrolo[3,4-C]pyrazole-5(1H,4H,6H) carbaldehyde derivatives |
| 02/14/2012 | US8114870 Method of treating disease states using substituted pyrazole compounds |
| 02/14/2012 | US8114869 Polymorph form II of tanaproget |
| 02/14/2012 | US8114868 Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
| 02/14/2012 | US8114867 Oxazolidinone antibiotic derivatives |
| 02/14/2012 | US8114866 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme |
| 02/14/2012 | US8114865 Indazole derivatives as kinase inhibitors for the treatment of cancer |
| 02/14/2012 | US8114864 Macrolide antibiotics and their use for medical purposes |
| 02/14/2012 | US8114863 Compounds comprising short aminoalcohol chains and metal complexes for medical imaging |
| 02/14/2012 | US8114862 TGR5 modulators and methods of use thereof |
| 02/14/2012 | US8114861 Compositions containing compounds having steroid structure and their use for inducing the proliferation and differentiation of stem cells of the organism |
| 02/14/2012 | US8114860 GABA-steroid antagonists and their use for the treatment of CNS disorders |
| 02/14/2012 | US8114859 2-methylene-(20S,25S)-19,27-dinor-(22E)-vitamin D analogs |
| 02/14/2012 | US8114858 Derivatives of 4- or 5-aminosalicylic acid |
| 02/14/2012 | US8114857 Derivatives of 4- or 5-aminosalicylic acid |
| 02/14/2012 | US8114856 Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents |
| 02/14/2012 | US8114855 Low density cosmetic formulations, cosmetic products containing the same and methods of treating hair, nails and/or skin using the same |
| 02/14/2012 | US8114854 Crystalline forms of gemcitabine amide prodrug, compositions and use thereof |
| 02/14/2012 | US8114853 Methods of treating smooth muscle cell disorders |
| 02/14/2012 | US8114851 Double stranded RNA packaged in liposome for use therapeutic tool in treatment of cell proliferative and viral disorders; Antisense oligonucleotide for use in prevention and treatment of viral and tumor disorders; gene expression inhibition; RNA interference |
| 02/14/2012 | US8114848 Immunomodulatory oligonucleotides |
| 02/14/2012 | US8114847 Selective inhibitors of translesion DNA replication |
| 02/14/2012 | US8114830 Polypeptoid pulmonary surfactants |
| 02/14/2012 | US8114603 collecting a blood sample from the subject; andmeasuring the levels of Triggering Receptor Expressed on Myeloid cells (TREM-1) splice variant protein in sample, a decrease in the levels of TREM-1 splice variant indicates an inflammatory response |
| 02/14/2012 | US8114601 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 02/14/2012 | US8114453 Synergistically heat stable oil media having eicosa pentanoic acid (EPA) and docosa hexaenoic acid (DHA) |
| 02/14/2012 | US8114447 Extraction of sterol and fatty acid using ethanol and water; efficiency |
| 02/14/2012 | US8114442 Transdermal pharmaceutical delivery compositions |
| 02/14/2012 | US8114440 Pharmaceutical compositions for the administration of aptamers |
| 02/14/2012 | US8114439 Synthetic peptides reducing or removing bags formed under the lower eye contour and their use in cosmetic or dermopharmaceutical compositions |
| 02/14/2012 | US8114435 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID |
| 02/14/2012 | US8114434 Diclofenac sodium patches for topical treatment of pain |
| 02/14/2012 | US8114432 Ion transport mechanism interference agent is capable of interfering with the cellular mechanisms of lens epithelial cells while leaving other ocular cells unharmed |
| 02/14/2012 | US8114423 Deodorant compositions |
| 02/14/2012 | US8114418 Chimeric immunomodulatory compounds and methods of using the same—IV |
| 02/14/2012 | US8114413 Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin |
| 02/14/2012 | US8114400 Aza-bicyclic compounds and their use as stimulators of soluble guanylate cyclase |
| 02/14/2012 | US8114394 Use of IL-1 antagonists to treat gout |
| 02/14/2012 | US8114393 Methods and compositions for phosphate binding |
| 02/14/2012 | US8114383 Abuse-proofed dosage form |
| 02/14/2012 | US8114379 Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process |
| 02/14/2012 | CA2651653C 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| 02/14/2012 | CA2570406C Use of botulinum toxin for treating pelvic pain |
| 02/14/2012 | CA2549730C Chemically modified small molecules |
| 02/14/2012 | CA2536429C 7-(4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative |
| 02/14/2012 | CA2470665C Process for the preparation of glucosamine salts |
| 02/14/2012 | CA2463154C Heterocyclic compounds and methods of use |
| 02/14/2012 | CA2402160C Heparinase iii and uses thereof |
| 02/11/2012 | CA2712747A1 Combinatory cancer treatment |
| 02/09/2012 | WO2012019204A2 Therapeutic agent for intranasal administration and method of making and using same |
| 02/09/2012 | WO2012019203A2 Therapeutic agent for intranasal administration and method of making and using same |
| 02/09/2012 | WO2012019188A2 Methods and compositions for the inhibition of fructokinase |
| 02/09/2012 | WO2012019168A2 Engineered nucleic acids and methods of use thereof |
| 02/09/2012 | WO2012019165A2 Methods of inhibition of protein fucosylation in vivo using fucose analogs |
| 02/09/2012 | WO2012019139A1 Combined drug delivery methods and apparatus |
| 02/09/2012 | WO2012019127A2 Combination yeast-based immunotherapy and arginine therapy for the treatment of myeloid-derived supressor cell-associated diseases |
| 02/09/2012 | WO2012019123A1 Processes for preparing tubulysins |
| 02/09/2012 | WO2012019113A2 Inhibitors of erk for developmental disorders of neuronal connectivity |
| 02/09/2012 | WO2012019093A1 Synthetic compounds and methods to decrease nicotine self-administration |
| 02/09/2012 | WO2012019086A2 Inhibition of lar phosphatase to enhance therapeutic angiogenesis |
| 02/09/2012 | WO2012019076A1 Compositions and methods for preventing and treating cardiac ischemia/reperfusion injury |
| 02/09/2012 | WO2012019071A1 Methods of preventing and treating sarcopenia |
| 02/09/2012 | WO2012019056A1 Amino-iso-indole, amino-aza-iso-indole, amino-dihydroisoquinoline and amino-benzoxazine compounds as beta-secretase modulators and methods of use |
| 02/09/2012 | WO2012019053A2 Methods for impairing the p53/hdm2 auto-regulatory loop in multiple myeloma development using mir-192, mir-194 and mir-215 |